Literature DB >> 17133482

JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation.

David E Smart1, Karen Green, Fiona Oakley, Jonathan B Weitzman, Moshe Yaniv, Gary Reynolds, Jelena Mann, Harry Millward-Sadler, Derek A Mann.   

Abstract

JunD is implicated in the regulation of hepatic stellate cell (HSC) activation and liver fibrosis via its transcriptional regulation of the tissue inhibitor of metalloproteinases-1 (TIMP-1) gene. In the present study we found in vivo evidence of a role for JunD in fibrogenesis. Expression of JunD was demonstrated in alpha-SMA-positive activated HSCs of fibrotic rodents and human livers. The junD-/- mice were protected from carbon tetrachloride-induced fibrosis. The livers of injured junD-/- mice displayed significantly reduced formation of fibrotic crosslinked collagen and a smaller number of alpha-SMA-positive HSCs compared with those of wild-type (wt) mice. Hepatic TIMP-1 mRNA expression in injured junD-/- mice was 78% lower and in culture activated junD-/- HSCs was 50%-80% lower than that in wt mice. In examining the signal transduction mechanisms that regulate JunD-dependent TIMP-1 expression, we found a role for phosphorylation of the Ser100 residue of JunD but ruled out JNK as a mediator of this event, suggesting ERK1/2 is utilized. In conclusion, a signaling pathway for the development of fibrosis involves the regulation of TIMP-1 expression by phosphorylated JunD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133482     DOI: 10.1002/hep.21436

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 2.  A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.

Authors:  Laurent Ehrlich; Chad Hall; Fanyin Meng; Terry Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  Gene Expr       Date:  2017-04-28

Review 3.  A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.

Authors:  Ekihiro Seki; David A Brenner; Michael Karin
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

4.  The role of heterodimeric AP-1 protein comprised of JunD and c-Fos proteins in hematopoiesis.

Authors:  Sung-Young Lee; Jaeho Yoon; Mee-Hyun Lee; Sung Keun Jung; Dong Joon Kim; Ann M Bode; Jaebong Kim; Zigang Dong
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

5.  Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells.

Authors:  Tsung-Chuan Ho; Show-Li Chen; Shou-Chuan Shih; Ju-Yun Wu; Wen-Hua Han; Huey-Chuan Cheng; Su-Lin Yang; Yeou-Ping Tsao
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

6.  Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells.

Authors:  Ying-Hua Chen; Tian Lan; Jing Li; Chun-Hui Qiu; Teng Wu; Hong-Ju Gou; Min-Qiang Lu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.

Authors:  Johannes Kluwe; Jean-Philippe Pradere; Geum-Youn Gwak; Ali Mencin; Samuele De Minicis; Christoph H Osterreicher; Jordi Colmenero; Ramon Bataller; Robert F Schwabe
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

Review 8.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

9.  Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.

Authors:  Mohammad R Ebrahimkhani; Fiona Oakley; Lindsay B Murphy; Jelena Mann; Anna Moles; Maria J Perugorria; Elizabeth Ellis; Anne F Lakey; Alastair D Burt; Angela Douglass; Matthew C Wright; Steven A White; Fabrice Jaffré; Luc Maroteaux; Derek A Mann
Journal:  Nat Med       Date:  2011-11-27       Impact factor: 53.440

10.  Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.

Authors:  James Pritchett; Emma Harvey; Varinder Athwal; Andrew Berry; Cliff Rowe; Fiona Oakley; Anna Moles; Derek A Mann; Nicoletta Bobola; Andrew D Sharrocks; Brian J Thomson; Abed M Zaitoun; William L Irving; Indra N Guha; Neil A Hanley; Karen Piper Hanley
Journal:  Hepatology       Date:  2012-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.